Soyeon
Analyst
UBS
Equibles does not estimate personal net worth.
About Soyeon
Soyeon is recorded as Analyst at UBS. Soyeon has spoken on 1 earnings call across 1 company, most recently for Acadia Pharmaceuticals Inc on November 4, 2026. The companies whose calls Soyeon spoke on are classified in the Healthcare sector.
Soyeon on recent calls
“I wanted to ask about the New Placid patent appeal by Aurobindo at the circuit court. There is an oral argument coming up on November 9th, next Monday, related to the 721 patent.”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current